General Practice United Against Hate

Doncaster Pharmacy First Collaborative Event Series

Session 3 – Infected Insect Bites Pathway & Referral Mechanisms
Thursday 22nd August 2024

Together with Doncaster Local Medical Committee (LMC) and the South Yorkshire Integrated Care Board (ICB), we are running a series of collaborative events for GP practice, community pharmacy, PCN and SY ICB Doncaster Place colleagues to explore how collaboration can support all members of the primary care team to deliver improved outcomes via the new Pharmacy First service.

Building on the success of our previous events, we’re excited to announce our third collaborative session, scheduled for Thursday 22nd August. This event will focus on the Infected Insect Bites pathway and referral mechanisms for GP practices.

The session will be divided into two parts:

  1. Clinical Overview: Delivered by Rao Kolusu, Prescribing Lead for Doncaster Place and GP at Hatfield Health Centre, this session will cover the clinical aspects of diagnosing and treating infected insect bites. Attendees will also gain valuable insights and practical tips for reception staff on referring patients with insect bites. We will also discuss strategies to enhance service delivery for both practice and pharmacy teams by effectively utilising the clinical pathway.
  1. Referral Mechanisms: The second part will delve into various referral mechanisms that can be used to refer to pharmacy and demonstrate how reception teams can streamline patient access by efficiently sending referrals to community pharmacies. A session not to be missed for those wanting to either start making referrals / understand how to make referrals more easily! This is also a great opportunity for community pharmacy teams to understand the mechanisms practices will use to send referrals to your pharmacy.

The event will be held at Mount Pleasant Hotel, Great N Road, Rossington, Doncaster, DN11 0HW and will start with networking and a buffet from 6:30pm with the Pharmacy First session starting at 7.00pm and closing at 8.30pm. This will be followed by a short update from our sponsors, Boehringer Ingelheim for those who wish to stay a little while longer.

Please register using the link below by 16th August, 5pm so we can confirm numbers for catering 

https://forms.office.com/e/MBARShzHbp

Once you’ve booked your place, please let us know if you can no longer attend so we can adjust catering requirements by contacting info@cpsy.org.uk 

For more information about the other events in this series click here

Our thanks to Boehringer Ingelheim for sponsoring this session.

Government response to Doctors and Dentists Remuneration (DDRB) and the Additional Roles Reimbursement Scheme (ARRS)

Picture of Dr Amanda Doyle

Dr Amanda Doyle

National Director for Primary Care and Community Services, NHS England

Picture of Dr Claire Fuller

Dr Claire Fuller

National Medical Director for Primary Care, NHS England

Following the letter issued to general practice by the Secretary of State on 1 August, we are writing to provide additional information on how the funding and contract changes announced will be implemented.

The Government has agreed that it will fund in full the Review Body on Doctors and Dentists Remuneration (DDRB) pay recommendations for GPs.

As the Secretary of State has stated, the GP contract will be amended to uplift the pay elements of the contract by 6% (a further 4% in addition to the 2% already included in contract funding at the start of 2024/25), which will be backdated to 1 April 2024.

NHS England will work with the Department of Health and Social Care (DHSC) and the British Medical Association’s General Practitioners Committee (GPC England) to update the Statement of Financial Entitlements (SFE) so the uplift can be passed on to practices as soon as possible via Global Sum.

The uplift to the Global Sum is calculated to cover all practice staff – not just GP partners and salaried GPs. This includes practice nurses, reception, management and other practice staff. We firmly expect GP partners to honour the intent of this uplift and award the full 6% pay rises to all their staff.

Once the details are finalised, NHS England will confirm when practices can expect to receive uplifted payments via the Primary Care bulletin.

In response to strong feedback from the profession, and to help solve the immediate issue of GP unemployment amongst recently qualified GPs, additional funding of £82 million has also been announced to support the inclusion of recently qualified GPs in the ARRS in 2024/25. This issue is, in part, a result of more GPs qualifying following an increase in training places 3 years ago.

This scheme is intended to relieve the pressure on employment for this expanded cohort of GP staff – and is in addition to the anticipated recruitment of recently qualified GPs we would expect to take place – and funded through the practice contract in the normal way.

We are making an amendment to the primary care network directed enhanced service (PCN DES) for 2024/25 to expand the ARRS and to reimburse the employment costs for recently qualified GPs.

NHS England is releasing extra funds for 2024/25; while this is an emergency measure and we will work with the Government on longer term solutions to GP unemployment, we recognise this as a change to your operating costs that will be considered in future budget setting, as in previous years when the ARRS has been expanded and you have recruited additional staff.

Using the ARRS will enable ring-fenced funding to get to primary care networks (PCNs) quickly to employ over 1,000 additional GPs. NHS England will communicate revised ARRS entitlements (budgets) to PCNs, reflecting the separate ring-fenced element that is available for GPs.

As the new funding for GPs is complementary to the existing scheme and separately ring-fenced, it will ensure that the reimbursement of existing ARRS staff is not impacted by the introduction of GPs.

The additional funding will be available to fund the employment of GPs who have recently obtained their certificate of completion of training (CCT).

PCNs will be able to draw down funding from October 2024 – and the exact criteria for employing GPs will be set out in a revised Network Contract DES specification, on which we will consult with GPC England over the coming weeks. This will include ensuring that the GPs employed are in addition to the existing GP workforce employed by practices.

The existing ARRS portal will be updated so PCNs can use it to claim reimbursement for employing recently qualified GPs. This will allow for the quickest operationalisation of the ARRS changes and is a familiar reimbursement mechanism for PCNs.

This move has been made to expedite the employment of some newly qualified GPs, who may be struggling to secure a practice role. We recognise the ARRS has not previously been used to fund GP employment. We will engage with the profession and stakeholders to review this approach as we look to identify longer-term solutions to GP employment and general practice sustainability – including core GP capacity – as part of the future contract reform discussions.

We also recognise that there have been calls for the scheme to be expanded to include practice nurses. While our current focus is to respond to the immediate issue of GP unemployment among newly qualified GPs, we and Government will keep the scheme under review.

Thank you for all your hard work at what we appreciate is a challenging time.

Gender Identity Toolkit For General Practice

A Gender-identity-toolkit-for-general-practice-Template-2.0.pdf (igpm.org.uk) is available which practices might find helpful, as it is designed to support general practice teams when providing care to trans and non-binary patients. The toolkit consolidates statutory requirements and best practice guidance into an easily implementable, procedural resource, as well as highlighting a range of common themes in trans and non binary healthcare, from determining a suitable treatment pathway to updating a patient’s name and/or gender marker. The toolkit links to a variety of sources of information. Of particular note is the Royal College of General Practitioners (RCGP) guidance The role of the GP in transgender care Transgender care (rcgp.org.uk).

Care Quality Commission (CQC) MythBusters

CQC National Clinical Advisors and Policy Team issue guidance to clear up some common myths about CQC inspections, as well as sharing guidance on best practice, which practices may wish to be aware of. The following mythbusters have been added or updated in recent weeks:

BMA Sessional GP Conference – Diversity, Opportunity, Safety

A one-day conference specifically for sessional GPs / Free for BMA members / Fees apply for non-members Friday 20 September 2024 – 9.30 am to 4.30 pm BMA House, Tavistock Square, London WC1H 9JP

In person attendance at BMA House will offer a range of networking opportunities, with refreshments and lunch provided. Remote attendance is also available.

The aim of the event is to give information and updates on topical issues. Breakout groups will provide practical advice and guidance on a choice of topics in smaller groups:

  • Pensions for sessional GPs • Working in out of hours and urgent care settings
  • How to set up in private practice • Digital remote roles for GPs
  • Responding to performance concerns
  • Working with a disability Further information, including how to register, can be found here BMA sessional GP conference 2024: diversity, opportunity, safety

Seasonal Flu Immunisation Programme Vaccine

Sanofi has advised that the Recombinant Quadrivalent Influenza vaccine [QIVr] will, due to a supply issue, not be available for the flu vaccination programme for the 2024/25 season. The original Joint Committee on Vaccination and Immunisation (JCVI) recommendation was to use QIVr for adults aged 65 years and over, and also adults aged 16 to 64 who are in eligible groups. In the light of this change, NHS England has advised the following:

Aged 65 years and over Aged 18 to 64 years in risk groups 

  • adjuvanted quadrivalent influenza vaccine (aQIV)  
  • high-dose quadrivalent influenza vaccine (QIV-HD)

 The cell-based quadrivalent influenza vaccine (QIVc) can also be considered only when every attempt to use aQIV or QIV HD has been exhausted – evidence of this may be requested by the commissioner before reimbursement is agreed. 

Aged 18 to 59 years 

  • cell-based quadrivalent influenza vaccine (QIVc)

 Aged 60 to 64 years 

  • cell-based quadrivalent influenza vaccine (QIVc)
  • high-dose quadrivalent influenza vaccine (QIV-HD)

 The egg-grown quadrivalent influenza vaccine (QIVe) can also be considered only when every attempt to use QIVc, or in the case of those aged 60 -64 years also QIV-HD, has been exhausted – evidence of this may be requested by the commissioner before reimbursement is agreed.

As QIVr is only licensed for those aged 18 and over, this does not affect the immunisation programme for younger patients. For practices who have ordered QIVr, and who are participating in the 2024/25 immunisation programme, the primary alternative is QIV-HD [high dose quadrivalent influenza vaccine] which is licensed in the UK for those 60 and over. Otherwise, practices may seek to order additional supplies of aQIV [Adjuvanted Quadrivalent Influenza Vaccine] for those aged 65 and over, and QIVc [Cell based Quadrivalent Influenza Vaccine] for those under 65 years. NHSE has updated the list of influenza vaccines marketed in the UK. Influenza vaccines marketed in the UK – GOV.UK (www.gov.uk)

Parliamentary Constituency Data

We are grateful to Bedfordshire and Hertfordshire LMC for collating parliamentary constituency data from NHS Digital sources. Data is available for general practices in the 3 Doncaster Parliamentary Constituencies relating to changes in population and staffing affecting the delivery of general practice services. It compares the changes affecting general practice services between 2014 and 2024 and can be accessed here GP Data (zoho.eu)  – select “Region” (Yorkshire and the Humber) and “Parliamentary Constituency” (scroll down to select a constituency to view the local data).

We hope you find this helpful in highlighting many of the concerns raised by patients and staff, with the recognition that GPs are being asked to care for more and more patients whilst experiencing a decline in surgery and GP numbers over this timescale.

Respect

SYICB palliative and end of life care strategy

Medicines Optimisation Bulletin

LMC Buying Group

Doncaster LMC is been a member of the LMC Buying Groups Federation. This means that practices can access the discounts the Buying Group has negotiated on a wide range of products and services.  If you’re not sure what the Buying Group is all about then this short video explains what they do: https://www.youtube.com/watch?v=FekMwFI5ILg.   

 

By registering with the Buying Group:  www.lmcbuyinggroups.co.uk/members/, you can view all the suppliers’ pricing, contact details and request quotes. The Buying Group also offers any member practice a free cost analysis which demonstrates how much money your practice could save just by swapping to buying group suppliers.  Tel: 0115 979 6910  Email: info@lmcbuyinggroups.co.uk   Website: www.lmcbuyinggroups.co.uk